Six abstracts presented at the American Diabetes Association 84th Scientific Sessions explored how different interventions or factors can impact type 2 diabetes (T2D) management.
Managing type 2 diabetes (T2D) involves a multi-pronged approach. It relies on lifestyle changes, medications, blood sugar monitoring, and ongoing education. However, research in T2D management is ever-changing; by continuously exploring and refining these pillars of management, health care professionals can optimize health outcomes for patients with the condition.
Six abstracts presented at the American Diabetes Association 84th Scientific Sessions, held June 21 to 24 in Orlando, Florida, explored how different interventions or factors, such as diet and nutrition, medication, or comorbidities, can impact T2D management.
Click here for more of our coverage from ADA 2024.
READ MORE: Diabetes Resource Center
Don’t get left behind: Sign up today for our free Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips delivered straight to your inbox.
GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status
October 1st 2024Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.
GLP-1s May Protect Against Cardiovascular Outcomes Regardless of Diabetes Status
October 1st 2024Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.
2 Commerce Drive
Cranbury, NJ 08512